REPURPOSING BASED IDENTIFICATION OF NOVEL INHIBITORS AGAINST MMPS5-MMPL5 EFFLUX PUMP OF MYCOBACTERIUM SMEGMATIS: A COMBINED IN SILICO AND IN VITRO STUDY Article Shahbaaz M., Maslov D.A., Vatlin A.A., Danilenko V.N., Grishina M., Christoffels A. Biomedicines. MDPI AG. Vol. 10. 2022.
SYNTHESIS AND CHARACTERIZATION OF NOVEL 2-ACYL-3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDES AS POTENTIAL ANTIMICROBIAL AGENTS Article Buravchenko G.I., Maslov D.A., Alam M.S., Grammatikova N.E., Frolova S.G., Vatlin A.A., Tian X., Ivanov I.V., Bekker O.B., Kryakvin M.A., Dontsova O.A., Danilenko V.N., Zhang T., Shchekotikhin A.E. Pharmaceuticals. MDPI AG. Vol. 15. 2022.
TRANSCRIPTOMIC PROFILE OF MYCOBACTERIUM SMEGMATIS IN RESPONSE TO AN IMIDAZO[1,2-B][1,2,4,5]TETRAZINE REVEALS ITS POSSIBLE IMPACT ON IRON METABOLISM Article Vatlin A.A., Shitikov E.A., Shahbaaz M., Bespiatykh D.A., Klimina K.M., Christoffels A., Danilenko V.N., Maslov D.A. Frontiers in Microbiology. Frontiers Media S.A.. Vol. 12. 2021.